Rogers; Bruce Nelsen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rogers; Bruce Nelsen.The latest application filed is for "heteroaromatic compounds and their use as dopamine d1 ligands".

Company Profile

10.23.27

Rogers; Bruce Nelsen - Belmont MA
Rogers; Bruce Nelsen - Mystic CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20210300899 - Brodney; Michael Aaron ; et al.	2021-09-30
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 11,014,909 - Brodney , et al. May 25, 2	2021-05-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20200283407 - Brodney; Michael Aaron ; et al.	2020-09-10
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,723,711 - Butler , et al.	2020-07-28
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,696,658 - Brodney , et al. June 30, 2	2020-06-30
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl App 20190382359 - BUTLER; CHRISTOPHER RYAN ; et al.	2019-12-19
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190367485 - Brodney; Michael Aaron ; et al.	2019-12-05
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,428,034 - Butler , et al. October 1, 2	2019-10-01
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,421,744 - Brodney , et al. Sept	2019-09-24
Heteroarylphenoxy benzamide kappa opioid ligands Grant 10,316,021 - Kablaoui , et al.	2019-06-11
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190002439 - BRODNEY; MICHAEL AARON ; et al.	2019-01-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180346477 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-12-06
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,093,655 - Brodney , et al. October 9, 2	2018-10-09
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,077,272 - Gray , et al. September 18, 2	2018-09-18
2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides Grant 10,028,962 - Brodney , et al. July 24, 2	2018-07-24
Heteroarylphenoxy Benzamide Kappa Opioid Ligands App 20180148432 - Kablaoui; Natasha Mariam ; et al.	2018-05-31
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180072750 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-03-15
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20180065943 - BUTLER; CHRISTOPHER RYAN ; et al.	2018-03-08
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180037571 - BRODNEY; MICHAEL AARON ; et al.	2018-02-08
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,868,744 - Gray , et al. January 16, 2	2018-01-16
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 9,845,301 - Butler , et al. December 19, 2	2017-12-19
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,822,097 - Brodney , et al. November 21, 2	2017-11-21
2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides App 20170304312 - Brodney; Michael Aaron ; et al.	2017-10-26
2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides Grant 9,744,173 - Brodney , et al. August 29, 2	2017-08-29
Heterocyclic compounds and their use as dopamine D1 ligands Grant 9,745,317 - Gray , et al. August 29, 2	2017-08-29
2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides App 20170151252 - Brodney; Michael Aaron ; et al.	2017-06-01
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides Grant 9,605,007 - Brodney , et al. March 28, 2	2017-03-28
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170057947 - BRODNEY; MICHAEL AARON ; et al.	2017-03-02
Heterocyclic Compounds And Their Use As Dopamine D1 Ligands App 20170044174 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037053 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-09
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20170029390 - BUTLER; CHRISTOPHER RYAN ; et al.	2017-02-02
2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides App 20170008911 - Brodney; Michael Aaron ; et al.	2017-01-12
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,843 - Davoren , et al. December 27, 2	2016-12-27
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,831 - Brodney , et al. December 27, 2	2016-12-27
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides Grant 9,428,523 - Brodney , et al. August 30, 2	2016-08-30
2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides App 20160152637 - Brodney; Michael Aaron ; et al.	2016-06-02
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides Grant 9,315,520 - Brodney , et al. April 19, 2	2016-04-19
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150344474 - DAVOREN; JENNIFER ELIZABETH ; et al.	2015-12-03
2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,- 3-Thiazol-4-yl Amides App 20150291621 - Brodney; Michael Aaron ; et al.	2015-10-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,139,561 - Brodney , et al. September 22, 2	2015-09-22
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,133,190 - Davoren , et al. September 15, 2	2015-09-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,107,923 - Brodney , et al. August 18, 2	2015-08-18
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150196561 - BRODNEY; MICHAEL AARON ; et al.	2015-07-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150175573 - BRODNEY; MICHAEL AARON ; et al.	2015-06-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150005313 - BRODNEY; MICHAEL AARON ; et al.	2015-01-01
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140336176 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-11-13
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 8,822,494 - Davoren , et al. September 2, 2	2014-09-02
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140128374 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-05-08
Positive allosteric modulators of the nicotinic acetylcholine receptor App 20080132551 - Rogers; Bruce Nelsen ; et al.	2008-06-05
Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane App 20080045512 - Duplantier; Allen J. ; et al.	2008-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.